Apoptosis in thymic epithelial tumors

Sung Hye Park, Han Kyeom Kim, Hanseong Kim, Jae Y. Ro

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We studied Fas/FasL, Bcl-2, and M30 CytoDeath in five cases of normal thymus and 41 cases of thymic epithelial tumors (TETs). In normal thymus, Fas was expressed in all epithelial cells, but not in thymic lymphocytes; FasL was weakly expressed only in medullary epithelium and Hassal's corpuscles. In TETs, Fas was expressed in all epithelial cells and lymphocytes, while FasL was differently expressed in epithelial cells of different subtypes of TETs, i.e., type A (2/2), AB (12/12), B1 (0/9), B1/B2 (0/3), B2 (0/1), B2/B3 (1/3), B3 (6/10) and C (1/1), but not in lymphocytes. Bcl2 protein was strongly expressed in medullary-derived lymphocytes of normal thymus and TETs, and weakly expressed only in medullary (spindle) epithelium of TETs. On M30 CytoDeath immunostaining, apoptotic indices were very low in all TETs (0-1.2). In conclusion, since FasL was expressed on the epithelial cells of lymphocyte-depleted (LD) areas of type B2/B3 and/or LD subtypes (type A, AB, B3, C), FasL expression could be relevant for the intracytoplasmic processes of T-cell selection and the regulation of the lymphoid cells inside the tumor, at least partly. However, tumorigenesis of TETs is not necessarily induced by abrogation of apoptosis.

Original languageEnglish
Pages (from-to)461-467
Number of pages7
JournalPathology Research and Practice
Volume198
Issue number7
DOIs
Publication statusPublished - 2002 Jan 1

Fingerprint

Lymphocytes
Apoptosis
Epithelial Cells
Thymus Gland
Epithelium
Thymic epithelial tumor
Carcinogenesis
T-Lymphocytes
Neoplasms
Proteins

Keywords

  • Bcl-2
  • Fas (APO-1)
  • FasL
  • M30 CytoDeath
  • Thymic epithelial tumors
  • Thymus

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Cell Biology

Cite this

Apoptosis in thymic epithelial tumors. / Park, Sung Hye; Kim, Han Kyeom; Kim, Hanseong; Ro, Jae Y.

In: Pathology Research and Practice, Vol. 198, No. 7, 01.01.2002, p. 461-467.

Research output: Contribution to journalArticle

Park, Sung Hye ; Kim, Han Kyeom ; Kim, Hanseong ; Ro, Jae Y. / Apoptosis in thymic epithelial tumors. In: Pathology Research and Practice. 2002 ; Vol. 198, No. 7. pp. 461-467.
@article{3b1158760fb84e5da8c7dce8a3a8ca0f,
title = "Apoptosis in thymic epithelial tumors",
abstract = "We studied Fas/FasL, Bcl-2, and M30 CytoDeath in five cases of normal thymus and 41 cases of thymic epithelial tumors (TETs). In normal thymus, Fas was expressed in all epithelial cells, but not in thymic lymphocytes; FasL was weakly expressed only in medullary epithelium and Hassal's corpuscles. In TETs, Fas was expressed in all epithelial cells and lymphocytes, while FasL was differently expressed in epithelial cells of different subtypes of TETs, i.e., type A (2/2), AB (12/12), B1 (0/9), B1/B2 (0/3), B2 (0/1), B2/B3 (1/3), B3 (6/10) and C (1/1), but not in lymphocytes. Bcl2 protein was strongly expressed in medullary-derived lymphocytes of normal thymus and TETs, and weakly expressed only in medullary (spindle) epithelium of TETs. On M30 CytoDeath immunostaining, apoptotic indices were very low in all TETs (0-1.2). In conclusion, since FasL was expressed on the epithelial cells of lymphocyte-depleted (LD) areas of type B2/B3 and/or LD subtypes (type A, AB, B3, C), FasL expression could be relevant for the intracytoplasmic processes of T-cell selection and the regulation of the lymphoid cells inside the tumor, at least partly. However, tumorigenesis of TETs is not necessarily induced by abrogation of apoptosis.",
keywords = "Bcl-2, Fas (APO-1), FasL, M30 CytoDeath, Thymic epithelial tumors, Thymus",
author = "Park, {Sung Hye} and Kim, {Han Kyeom} and Hanseong Kim and Ro, {Jae Y.}",
year = "2002",
month = "1",
day = "1",
doi = "10.1078/0344-0338-00283",
language = "English",
volume = "198",
pages = "461--467",
journal = "Pathology Research and Practice",
issn = "0344-0338",
publisher = "Urban und Fischer Verlag GmbH und Co. KG",
number = "7",

}

TY - JOUR

T1 - Apoptosis in thymic epithelial tumors

AU - Park, Sung Hye

AU - Kim, Han Kyeom

AU - Kim, Hanseong

AU - Ro, Jae Y.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - We studied Fas/FasL, Bcl-2, and M30 CytoDeath in five cases of normal thymus and 41 cases of thymic epithelial tumors (TETs). In normal thymus, Fas was expressed in all epithelial cells, but not in thymic lymphocytes; FasL was weakly expressed only in medullary epithelium and Hassal's corpuscles. In TETs, Fas was expressed in all epithelial cells and lymphocytes, while FasL was differently expressed in epithelial cells of different subtypes of TETs, i.e., type A (2/2), AB (12/12), B1 (0/9), B1/B2 (0/3), B2 (0/1), B2/B3 (1/3), B3 (6/10) and C (1/1), but not in lymphocytes. Bcl2 protein was strongly expressed in medullary-derived lymphocytes of normal thymus and TETs, and weakly expressed only in medullary (spindle) epithelium of TETs. On M30 CytoDeath immunostaining, apoptotic indices were very low in all TETs (0-1.2). In conclusion, since FasL was expressed on the epithelial cells of lymphocyte-depleted (LD) areas of type B2/B3 and/or LD subtypes (type A, AB, B3, C), FasL expression could be relevant for the intracytoplasmic processes of T-cell selection and the regulation of the lymphoid cells inside the tumor, at least partly. However, tumorigenesis of TETs is not necessarily induced by abrogation of apoptosis.

AB - We studied Fas/FasL, Bcl-2, and M30 CytoDeath in five cases of normal thymus and 41 cases of thymic epithelial tumors (TETs). In normal thymus, Fas was expressed in all epithelial cells, but not in thymic lymphocytes; FasL was weakly expressed only in medullary epithelium and Hassal's corpuscles. In TETs, Fas was expressed in all epithelial cells and lymphocytes, while FasL was differently expressed in epithelial cells of different subtypes of TETs, i.e., type A (2/2), AB (12/12), B1 (0/9), B1/B2 (0/3), B2 (0/1), B2/B3 (1/3), B3 (6/10) and C (1/1), but not in lymphocytes. Bcl2 protein was strongly expressed in medullary-derived lymphocytes of normal thymus and TETs, and weakly expressed only in medullary (spindle) epithelium of TETs. On M30 CytoDeath immunostaining, apoptotic indices were very low in all TETs (0-1.2). In conclusion, since FasL was expressed on the epithelial cells of lymphocyte-depleted (LD) areas of type B2/B3 and/or LD subtypes (type A, AB, B3, C), FasL expression could be relevant for the intracytoplasmic processes of T-cell selection and the regulation of the lymphoid cells inside the tumor, at least partly. However, tumorigenesis of TETs is not necessarily induced by abrogation of apoptosis.

KW - Bcl-2

KW - Fas (APO-1)

KW - FasL

KW - M30 CytoDeath

KW - Thymic epithelial tumors

KW - Thymus

UR - http://www.scopus.com/inward/record.url?scp=0036024694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036024694&partnerID=8YFLogxK

U2 - 10.1078/0344-0338-00283

DO - 10.1078/0344-0338-00283

M3 - Article

VL - 198

SP - 461

EP - 467

JO - Pathology Research and Practice

JF - Pathology Research and Practice

SN - 0344-0338

IS - 7

ER -